Business Strategies
> Generic Pharmaceuticals
The Company
develops and markets the generic equivalent of brand pharmaceuticals.
These products are marketed under the Barr Laboratories, Inc.
(Barr) label. Generic development is focused on generic products
that have one or more characteristics that will make it difficult
for other competitors to develop competing generic products.
The characteristics of the selected generic products the Company
pursues may include one or more of the following:
•
PRODUCT BARRIERS
- Difficult
to Formulate or Manufacture
•
PATENT BARRIERS
- Formulation,
Raw Material, Molecule
•
MARKETING BARRIERS
- Risk
Management Programs, Pregnancy Registry
The Company
believes that generic products with some or all of these characteristics
may produce higher returns for a longer period of time than
products without these characteristics.